Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/28275
Title: The mechanisms of apoptotic response to Resveratrol in metastatic breast cancer cells
Authors: NGUYEN THANH HUNG
Keywords: Resveratrol,apoptosis, ERK, metastasis,sustained activation
Issue Date: 21-Apr-2008
Source: NGUYEN THANH HUNG (2008-04-21). The mechanisms of apoptotic response to Resveratrol in metastatic breast cancer cells. ScholarBank@NUS Repository.
Abstract: Resveratrol, a phytoalexin found abundantly in grapes and other grape-related products, has been shown to be antiproliferative and protective against various types of cancers, including breast cancer. However, the precise underlying mechanisms are not well understood. In this study, we show that treatment with Resveratrol inhibits cell growth of a highly invasive and metastatic breast cancer cell line MDA-MB-231 by inducing apoptosis. RSVL-induced apoptosis correlates with sustained activation of ERK1/2 and suppression of Bcl-2 expression. Inhibition of ERK1/2 activation by its specific inhibitor or small interfering RNA abrogates Resveratrol-induced apoptosis and reverses the effect of Resveratrol on Bcl-2 suppression, while overexpression of MEK1, which is direct upstream of both ERK1/2, enhances apoptosis induced by Resveratrol. The other closely related MAPK members, p38 and JNK are not involved in apoptosis induced by Resveratrol in MDA-MB-231 cells. These results suggest that activation of ERK1/2 is required for Resveratrol-induced apoptosis in MDA-MB-231 cells.
URI: http://scholarbank.nus.edu.sg/handle/10635/28275
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
NguyenTH.01Chap.PDF.pdf1.8 MBAdobe PDF

OPEN

NoneView/Download
NguyenTH.02Chap.PDF.pdf1.2 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

154
checked on Jan 18, 2018

Download(s)

268
checked on Jan 18, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.